| Putative beta 4-adrenoceptors in rat ventricle mediate increases in contractile force and cell Ca2+: comparison with atrial receptors and relationship to (-)-[3H]-CGP 12177 binding. | |
| | |
MedLine Citation:
|
PMID: 10602323 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
1. We identified putative beta4-adrenoceptors by radioligand binding, measured increases in ventricular contractile force by (-)-CGP 12177 and (+/-)-cyanopindolol and demonstrated increased Ca2+ transients by (-)-CGP 12177 in rat cardiomyocytes. 2. (-)-[3H]-CGP 12177 labelled 13 - 22 fmol mg-1 protein ventricular beta1, beta2-adrenoceptors (pKD approximately 9.0) and 50 - 90 fmol mg-1 protein putative beta4-adrenoceptors (pKD approximately 7.3). The affinity values (pKi) for (beta1,beta2-) and putative beta4-adrenoceptors, estimated from binding inhibition, were (-)-propranolol 8.4, 5.7; (-)-bupranolol 9.7, 5.8; (+/-)-cyanopindolol 10.0,7.4. 3. In left ventricular papillary muscle, in the presence of 30 microM 3-isobutyl-1-methylxanthine, (-)-CGP 12177 and (+/-)-cyanopindolol caused positive inotropic effects, (pEC50, (-)-CGP 12177, 7.6; (+/-)-cyanopindolol, 7.0) which were antagonized by (-)-bupranolol (pKB 6.7 - 7.0) and (-)-CGP 20712A (pKB 6.3 - 6.6). The cardiostimulant effects of (-)-CGP 12177 in papillary muscle, left and right atrium were antagonized by (+/-)-cyanopindolol (pKP 7.0 - 7.4). 4. (-)-CGP 12177 (1 microM) in the presence of 200 nM (-)-propranolol increased Ca2+ transient amplitude by 56% in atrial myocytes, but only caused a marginal increase in ventricular myocytes. In the presence of 1 microM 3-isobutyl-1-methylxanthine and 200 nM (-)-propranolol, 1 microM (-)-CGP 12177 caused a 73% increase in Ca2+ transient amplitude in ventricular myocytes. (-)-CGP 12177 elicited arrhythmic transients in some atrial and ventricular myocytes. 5. Probably by preventing cyclic AMP hydrolysis, 3-isobutyl-1-methylxanthine facilitates the inotropic function of ventricular putative beta4-adrenoceptors, suggesting coupling to Gs protein-adenylyl cyclase. The receptor-mediated increases in contractile force are related to increases of Ca2+ in atrial and ventricular myocytes. The agreement of binding affinities of agonists with cardiostimulant potencies is consistent with mediation through putative beta4-adrenoceptors labelled with (-)-[3H]-CGP 12177. |
| | |
Authors:
|
D Sarsero; P Molenaar; A J Kaumann; N S Freestone |
Related Documents
:
|
6332953 - Effect of intraoperative propranolol on serum creatine kinase mb release in patients ha... 69503 - Re-entrant ventricular arrhythmias in the late myocardial infarction period. 4. mechani... 21957423 - Potential role of coronary computed tomography angiogram in cardiac preoperative evalua... |
Publication Detail:
|
Type: Comparative Study; In Vitro; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: British journal of pharmacology Volume: 128 ISSN: 0007-1188 ISO Abbreviation: Br. J. Pharmacol. Publication Date: 1999 Dec |
Date Detail:
|
Created Date: 2000-02-03 Completed Date: 2000-02-03 Revised Date: 2009-11-18 |
Medline Journal Info:
|
Nlm Unique ID: 7502536 Medline TA: Br J Pharmacol Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 1445-60 Citation Subset: IM |
Affiliation:
|
Department of Pharmacology, University of Melbourne, Parkville, 3052, Victoria, Australia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
1-Methyl-3-isobutylxanthine
/
pharmacology Adrenergic beta-Agonists / metabolism*, pharmacology Adrenergic beta-Antagonists / metabolism*, pharmacology Animals Arrhythmias, Cardiac / physiopathology Calcium / metabolism* Cardiotonic Agents / metabolism, pharmacology Female Heart Atria / drug effects, metabolism Heart Ventricles / drug effects, metabolism Kinetics Male Myocardial Contraction / drug effects* Norepinephrine / antagonists & inhibitors, pharmacology Papillary Muscles / drug effects Propanolamines / metabolism*, pharmacology Radioligand Assay Rats Rats, Sprague-Dawley Receptors, Adrenergic, beta / metabolism, physiology* Tritium |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Agonists; 0/Adrenergic beta-Antagonists; 0/Cardiotonic Agents; 0/Propanolamines; 0/Receptors, Adrenergic, beta; 0/adrenergic beta-4 receptor; 10028-17-8/Tritium; 28822-58-4/1-Methyl-3-isobutylxanthine; 51-41-2/Norepinephrine; 7440-70-2/Calcium; 81047-99-6/CGP 12177 |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effect of Gd3+ on bradykinin-induced catecholamine secretion from bovine adrenal chromaffin cells.
Next Document: Pharmacological characterization of antagonists of the C5a receptor.